The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
J Parkinsons Dis
.
2019;9(4):825.
doi: 10.3233/JPD-199003.
Authors
Diane Stephenson
,
Derek Hill
,
Jesse M Cedarbaum
,
Maria Tome
,
Spiros Vamvakas
,
Klaus Romero
,
Daniela J Conrado
,
David T Dexter
,
John Seibyl
,
Danna Jennings
,
Timothy Nicholas
,
Dawn Matthews
,
Zhiyong Xie
,
Syed Imam
,
Paul Maguire
,
David Russell
,
Mark Forrest Gordon
,
Glenn T Stebbins
,
Ed Somer
,
Jill Gallagher
,
Arthur Roach
,
Peter Basseches
,
Donald Grosset
,
Ken Marek
;
Critical Path for Parkinson’s Consortium
PMID:
31524182
PMCID:
PMC6878913
DOI:
10.3233/JPD-199003
No abstract available
Publication types
Published Erratum